Jiangsu Nhwa Pharmaceutical Co. Ltd. has patented substituted imidazole derivatives acting as α2-adrenoceptor agonists with sedative and/or analgesic and/or anesthetic and/or anxiolytic activity. As ...

Myrbetriq (mirabegron) – sold as Betanis and Betmiga in some markets – is an extended-release selective β3-adrenoceptor agonist therapy used to treat overactive bladder with symptoms of ...

Trimbow (beclometasone+formoterol+glycopyrronium) combines an inhaled corticosteroid (ICS), a long-acting beta adrenoceptor agonist (LABA) and a long-acting muscarinic antagonist (LAMA ...

For combination therapies, the pairing of monoamine reuptake inhibitors with presynaptic α2-adrenoceptor antagonists has shown promise in improving efficacy in TRD patients. Additionally, targeting ...

That is perhaps why there has been so much buzz surrounding the class of drug known as a GLP-1 agonist.

More U.S. adults believe it is a good thing than a bad thing for adults to use weight-loss drugs like Ozempic, Wegovy and other brands if they are struggling with obesity or have a health ...

No difference in thyroid cancer risk was found for adults with type 2 diabetes using a GLP-1 receptor agonist vs. those using a DPP-IV inhibitor. Women may have a lower risk for thyroid cancer ...

This important study provides new evidence on the role of norepinephrine (NE) release in the hippocampus in response to environmental transitions (event boundaries), providing a potential link between ...

Authors say large, multisite study should provide reassurance for short-term risk. HealthDay News — Glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is not associated with an increased risk for ...

Reduced risks seen for neurocognitive, coagulation, cardiometabolic disorders; increased risks seen for GI, arthritic disorders. HealthDay News — For people with diabetes, the use of glucagon ...